Higher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus

ABALI S., DEMİRCİOĞLU S., Atay Z., GÜRAN T., HALİLOĞLU B., BEREKET A.

PEDIATRIC DIABETES, vol.16, no.5, pp.361-366, 2015 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.1111/pedi.12167
  • Journal Name: PEDIATRIC DIABETES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.361-366
  • Keywords: children, detemir, glargine, HbA1c, T1D, TREAT-TO-TARGET, PHARMACOKINETIC PROPERTIES, ANALOGS DETEMIR, STEADY-STATE, DOUBLE-BLIND, NPH INSULIN, LONG, ADOLESCENTS, VARIABILITY, PROFILE
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

ObjectiveWe aimed to compare hemoglobin A1c (HbA1c), total and basal insulin doses, basal insulin injection frequencies, and body mass index (BMI) in children with type 1 diabetes mellitus (T1DM) who are receiving detemir and glargine as basal insulin in a basal-bolus therapy.